Manuscript citation: Raig ND, Surridge KJ, Sanz-Murillo M, Dederer V, Krämer A, Schwalm MP, Lattal NM, Elson L, Chatterjee D, Mathea S, Hanke T, Leschziner AE, Reck-Peterson SL, Knapp S Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2. Science Advances 11(23). doi: 10.1126/sciadv.adt2050 License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Protocol status: WorkingWe use this protocol and it's working
Created: October 26, 2023
Last Modified: May 31, 2024
Protocol Integer ID: 89960
Keywords: ASAPCRN, cryo-EM, LRRK2, inhibitors, lrrk2, e11 darpin complex guide for cryo, ii inhibitor, em grid preparation of fl, cryo, em grid preparation, sample preparation
Funders Acknowledgements:Aligning Science Across Parkinson's: ASAP
Grant ID: Grant ID: ASAP-000519